Part 8/Chapter 48/7-min read

Acute Mesenteric Ischemia, NOMI, and Bowel-Viability Pathways

Acute mesenteric ischemia is a vascular emergency because diagnostic delay turns a potentially reversible perfusion problem into transmural infarction. Management begins with clinical suspicion and dual-phase CT angiography, then rapid selection of endovascular, open, or hybrid revascularization, NOMI-specific hemodynamic rescue with selective vasodilator therapy where appropriate, and deliberate bowel-viability planning when viability is uncertain.

Edited by Tal M. Hörer MD, PhD · David T. McGreevy MD, PhD·Reviewed ·7 sections · 41 references

Listen to this chapter10 min · AI audio edition · two hostsAI narration

Emergency handoff / trauma debrief: Urgent but calm: frame the initial recognition, the sequence of decisions, transfer/workflow, and what changes the plan.

General medical education, not patient-specific advice.

Choose the hosts

Definition and presentation

Acute mesenteric ischemia is a time-critical interruption of intestinal blood flow progressing to transmural necrosis if untreated. Across modern cohorts, the pooled 30-day mortality remains between 40 and 60%. Mechanisms include embolic superior mesenteric artery occlusion, acute in-situ thrombosis on chronic atherosclerotic disease, mesenteric venous thrombosis, and non-occlusive mesenteric ischemia (NOMI) in a low-flow state .

Presenting features include:

  • Severe, persistent, poorly localized abdominal pain disproportionate to physical examination findings.
  • High-risk cardiovascular history: atrial fibrillation, recent myocardial infarction, peripheral arterial disease, or heart failure.
  • Preceding chronic post-prandial pain or weight loss (characterizes acute-on-chronic thrombosis).
  • Peritonitis, abdominal rigidity, persistent metabolic deterioration, or shock, which indicate irreversible transmural infarction .

Diagnosis and stratification

Diagnosis rests on clinical suspicion and imaging, not on biomarkers. Serum lactate elevation reflects late metabolic failure and systemic hypoperfusion; a normal lactate does not rule out mucosal ischemia and does not safely preclude imaging . Leucocytosis, D-dimer, and intestinal fatty acid binding protein demonstrate moderate diagnostic performance but are insufficient for definitive diagnosis .

Dual-phase contrast-enhanced computed tomography (CT) angiography, obtaining both arterial and portal-venous phases, is the diagnostic standard. The protocol delivers a pooled sensitivity of 93 to 96% and specificity above 90% . That sensitivity is high but not perfect, so a negative CT angiogram does not exclude the diagnosis: when the scan is negative and clinical suspicion remains high, escalate to catheter mesenteric angiography or operative exploration rather than treating a negative scan as reassurance . The scan assesses target vessel patency, identifies the etiology, characterizes bowel injury (reduced mural enhancement, pneumatosis, portal venous gas, free fluid, perforation), and maps revascularization anatomy . Renal dysfunction does not contraindicate CT angiography in suspected acute mesenteric ischemia . Duplex ultrasound is operator-dependent and insufficient for acute decision-making when bowel viability is threatened .

Management and revascularization logic

The primary modifiable determinant of survival is time to revascularization. The risk of irreversible transmural infarction rises sharply beyond 24 hours from symptom onset, mandating simultaneous rather than sequential diagnostic, operative, and resuscitation workstreams . Once the diagnosis is made, start early systemic anticoagulation with therapeutic heparin alongside resuscitation, in arterial embolic and thrombotic as well as venous disease, before or during definitive revascularization. The definitive intervention choice turns on etiology, mesenteric anatomy, and the presence of peritonitis .

Management thresholds and pathways

  • Suspected NOMI

    Anatomic or clinical criterion
    Patent arterial trunk with low-flow shock state
    Preferred pathway
    Hemodynamic resuscitation, vasopressor reduction, and selective intra-arterial vasodilators
    Citation

  • Stable, no peritonitis

    Anatomic or clinical criterion
    Suitable proximal or mid-vessel embolic occlusion
    Preferred pathway
    Endovascular aspiration thrombectomy, thrombolysis, or stenting
    Citation

  • Stable, no peritonitis

    Anatomic or clinical criterion
    Thrombotic ostial occlusion unsuitable for antegrade crossing
    Preferred pathway
    Open revascularization
    Citation

  • Peritonitis or uncertain viability

    Anatomic or clinical criterion
    Any occlusive anatomy
    Preferred pathway
    Immediate laparotomy with open revascularization or hybrid retrograde open mesenteric stenting (ROMS)
    Citation

  • Mesenteric venous thrombosis

    Anatomic or clinical criterion
    Venous occlusion without peritonitis or bowel compromise
    Preferred pathway
    Prompt systemic anticoagulation with therapeutic heparin; laparotomy and bowel resection reserved for peritonitis or bowel compromise, with a hypercoagulable and thrombophilia workup
    Citation

  • Prohibitive risk

    Anatomic or clinical criterion
    Established multi-organ failure with unsalvageable advanced necrosis
    Preferred pathway
    Deliberate non-intervention and palliative care
    Citation
  1. Assess clinical urgency and presence of peritonitis. Peritonitis dictates mandatory laparotomy to inspect bowel viability, shifting isolated percutaneous interventions to an open or hybrid approach.
  2. Define the mechanism. Endovascular-first therapy is preferred for anatomically suitable, non-peritonitic embolic or thrombotic occlusive disease.
  3. Manage anatomical constraints. Acute-on-chronic thrombosis often presents a heavily calcified ostium; if antegrade crossing fails, transition to open surgery or retrograde open mesenteric stenting (ROMS).
  4. Establish medical management. NOMI mandates correcting systemic shock and withdrawing vasoconstrictors prior to or alongside targeted intra-arterial vasodilators. Routine secondary prevention targets are subordinated to acute hemodynamic resuscitation.
  5. Treat mesenteric venous thrombosis medically first. Venous occlusion is managed primarily with prompt systemic anticoagulation using therapeutic heparin, reserving laparotomy and bowel resection for peritonitis or bowel compromise, and a hypercoagulable and thrombophilia workup is indicated .

Endovascular, open, and hybrid revascularization

Endovascular-first revascularization is associated with lower in-hospital mortality than open surgery in highly selected patients without peritonitis . Embolic occlusions are typically addressed with aspiration thrombectomy or catheter-directed techniques. Acute-on-chronic thrombosis requires recanalization and stenting of the heavily calcified ostium, carrying a higher risk of access failure .

Hybrid ROMS permits simultaneous direct bowel inspection and revascularization while bypassing antegrade access difficulties. The superior mesenteric artery is exposed at laparotomy, accessed retrogradely, and stented across the origin under fluoroscopy . Primary open embolectomy, endarterectomy, or bypass remains indicated when percutaneous options are anatomically unsuitable or when antegrade endovascular attempts fail . Adjuvant intra-arterial vasodilator infusion is used post-revascularization to treat secondary vasospasm, linking to reduced short-term mortality in observational series .

Non-occlusive mesenteric ischemia (NOMI)

NOMI is characterized by severe splanchnic vasoconstriction without a discrete occluding lesion, typically occurring in the context of shock, high-dose vasopressor use, severe heart failure, sepsis, or post-cardiac surgery recovery . Primary treatment focuses on correcting the underlying low-flow state via volume optimization, perfusion support, and reduction of systemic vasoconstrictor burden. In a sedated or ventilated patient who cannot report pain, an unexplained lactate rise, feeding intolerance, abdominal distension, an escalating vasopressor requirement, or new bowel-hypoperfusion signs on CT should lower the threshold for mesenteric imaging.

Selective mesenteric intra-arterial vasodilator infusion (using papaverine, alprostadil, or iloprost) serves as a medical adjunct once the diagnosis is angiographically confirmed . Mortality remains between 50 and 70% due to concurrent multiorgan failure . Clinical deterioration or the onset of peritonitis mandates surgical exploration, as vasodilator infusion does not reverse transmural necrosis.

Bowel-viability assessment and second-look laparotomy

Intraoperative assessment differentiates frankly necrotic bowel requiring immediate resection from borderline segments exhibiting duskiness, sluggish peristalsis, weak arterial signals, or a non-bleeding cut edge. Indocyanine green (ICG) fluorescence angiography clarifies microvascular perfusion boundaries, reducing extended or unnecessary resections in the borderline zone . Contrast-enhanced ultrasound and tissue spectroscopy offer supplementary intraoperative imaging, though practice remains center-dependent .

A planned second-look laparotomy at 24 to 48 hours is standard practice when viability remains uncertain following revascularization. This strategy protects the patient from unrecognised progressive necrosis while avoiding massive prophylactic resection .

Areas of controversy

  • Endovascular versus open mortality advantage: While pooled analyses report lower perioperative mortality for endovascular-first approaches, the data are heavily confounded by selection bias. Endovascular cohorts systematically include fewer patients with peritonitis or established transmural necrosis; no randomized trial isolates the revascularization technique's effect from baseline shock severity .
  • Standardization of vasodilator therapy: The specific agent, dose, and duration for selective intra-arterial vasodilator infusion in NOMI and post-revascularization vasospasm vary widely across centers. Evidence relies on observational registry data rather than prospective validation .
  • Advanced viability adjuncts: The absolute reduction in short-bowel syndrome achieved by contrast-enhanced ultrasound and tissue spectroscopy remains observational, and standard visual assessment combined with a second-look laparotomy continues to anchor practice .
  • Dominant mortality predictors: Thirty-day mortality is driven chiefly by advanced age, bowel necrosis at the index operation, organ and renal failure (high SOFA score), delayed diagnosis, and a NOMI etiology; of these, time to diagnosis and revascularization is the one modifiable lever.

References

  1. 1.
    Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery. World journal of emergency surgery: WJES. 2022.
    PubMed-indexed articleClinical practice guideline2022

    Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery. World journal of emergency surgery: WJES. 2022. doi:10.1186/s13017-022-00443-x.

    PubMedDOI
  2. 2.
    Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery. 2017.
    PubMed-indexed articleClinical practice guideline2017

    Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery. 2017. doi:10.1186/s13017-017-0150-5.

    PubMedDOI
  3. 3.
    Mortality of acute mesenteric ischemia remains unchanged despite significant increase in utilization of endovascular techniques. Vascular. 2016.
    PubMed-indexed articleRegistry / cohort2016

    Mortality of acute mesenteric ischemia remains unchanged despite significant increase in utilization of endovascular techniques. Vascular. 2016. doi:10.1177/1708538115577730.

    PubMedDOI
  4. 4.
    Predictors of Mortality in Acute Mesenteric Ischemia: A Systematic Review and Meta-Analysis. The Journal of surgical research. 2022.
    PubMed-indexed articleMeta-analysis / systematic review2022

    Predictors of Mortality in Acute Mesenteric Ischemia: A Systematic Review and Meta-Analysis. The Journal of surgical research. 2022. doi:10.1016/j.jss.2022.01.022.

    PubMedDOI
  5. 5.
    Acute mesenteric ischemia. Current gastroenterology reports. 2008.
    PubMed-indexed articleReview2008

    Acute mesenteric ischemia. Current gastroenterology reports. 2008. doi:10.1007/s11894-008-0065-0.

    PubMedDOI
  6. 6.
    Diagnosis and management of acute mesenteric ischemia: What you need to know. The journal of trauma and acute care surgery. 2025.
    PubMed-indexed articleReview2025

    Diagnosis and management of acute mesenteric ischemia: What you need to know. The journal of trauma and acute care surgery. 2025. doi:10.1097/ta.0000000000004585.

    PubMedDOI
  7. 7.
    Acute Mesenteric Ischaemia: Think About It, Don't Think Too Long, and Stick to the Guidelines. European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery. 2025.
    PubMed-indexed article2025

    Acute Mesenteric Ischaemia: Think About It, Don't Think Too Long, and Stick to the Guidelines. European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery. 2025. doi:10.1016/j.ejvs.2025.06.020.

    PubMedDOI
  8. 8.
    Normal Lactate and Unenhanced CT-Scan Result in Delayed Diagnosis of Acute Mesenteric Ischemia. The American journal of gastroenterology. 2020.
    PubMed-indexed article2020

    Normal Lactate and Unenhanced CT-Scan Result in Delayed Diagnosis of Acute Mesenteric Ischemia. The American journal of gastroenterology. 2020. doi:10.14309/ajg.0000000000000836.

    PubMedDOI
  9. 9.
    Serum lactate and acute mesenteric ischaemia: An observational, controlled multicentre study. Anaesthesia, critical care & pain medicine. 2022.
    PubMed-indexed articleRegistry / cohort2022

    Serum lactate and acute mesenteric ischaemia: An observational, controlled multicentre study. Anaesthesia, critical care & pain medicine. 2022. doi:10.1016/j.accpm.2022.101141.

    PubMedDOI
  10. 10.
    Diagnostic accuracy of novel serological biomarkers to detect acute mesenteric ischemia: a systematic review and meta-analysis. Internal and emergency medicine. 2017.
    PubMed-indexed articleMeta-analysis / systematic review2017

    Diagnostic accuracy of novel serological biomarkers to detect acute mesenteric ischemia: a systematic review and meta-analysis. Internal and emergency medicine. 2017. doi:10.1007/s11739-017-1668-y.

    PubMedDOI
  11. 11.
    Diagnostic accuracy of hematological parameters in Acute mesenteric ischemia-A systematic review. International journal of surgery (London, England). 2019.
    PubMed-indexed articleMeta-analysis / systematic review2019

    Diagnostic accuracy of hematological parameters in Acute mesenteric ischemia-A systematic review. International journal of surgery (London, England). 2019. doi:10.1016/j.ijsu.2019.04.005.

    PubMedDOI
  12. 12.
    Diagnostic accuracy of multidetector CT in acute mesenteric ischemia: systematic review and meta-analysis. Radiology. 2010.
    PubMed-indexed articleMeta-analysis / systematic review2010

    Diagnostic accuracy of multidetector CT in acute mesenteric ischemia: systematic review and meta-analysis. Radiology. 2010. doi:10.1148/radiol.10091938.

    PubMedDOI
  13. 13.
    Radiological diagnosis of acute mesenteric ischemia in adult patients: a systematic review and meta-analysis. Scientific reports. 2025.
    PubMed-indexed articleMeta-analysis / systematic review2025

    Radiological diagnosis of acute mesenteric ischemia in adult patients: a systematic review and meta-analysis. Scientific reports. 2025. doi:10.1038/s41598-025-94846-w.

    PubMedDOI
  14. 14.
    Acute Mesenteric Ischemia: Multidetector CT Findings and Endovascular Management. Radiographics: a review publication of the Radiological Society of North America, Inc. 2018.
    PubMed-indexed articleReview2018

    Acute Mesenteric Ischemia: Multidetector CT Findings and Endovascular Management. Radiographics: a review publication of the Radiological Society of North America, Inc. 2018. doi:10.1148/rg.2018170163.

    PubMedDOI
  15. 15.
    Editor's Choice - Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). 2017.
    PubMed-indexed articleClinical practice guideline2017

    Editor's Choice - Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). 2017. doi:10.1016/j.ejvs.2017.01.010.

    PubMedDOI
  16. 16.
    Acute Mesenteric Ischemia: Pathophysiology-based Approach to Imaging Findings and Diagnosis. Radiographics: a review publication of the Radiological Society of North America, Inc. 2025.
    PubMed-indexed articleReview2025

    Acute Mesenteric Ischemia: Pathophysiology-based Approach to Imaging Findings and Diagnosis. Radiographics: a review publication of the Radiological Society of North America, Inc. 2025. doi:10.1148/rg.250012.

    PubMedDOI
  17. 17.
    Duplex ultrasound in the early diagnosis of acute mesenteric ischemia: a longitudinal cohort multicentric study. European journal of emergency medicine: official journal of the European Society for Emergency Medicine. 2017.
    PubMed-indexed articleRegistry / cohort2017

    Duplex ultrasound in the early diagnosis of acute mesenteric ischemia: a longitudinal cohort multicentric study. European journal of emergency medicine: official journal of the European Society for Emergency Medicine. 2017. doi:10.1097/mej.0000000000000378.

    PubMedDOI
  18. 18.
    ESTES guidelines: acute mesenteric ischaemia. European journal of trauma and emergency surgery: official publication of the European Trauma Society. 2016.
    PubMed-indexed articleClinical practice guideline2016

    ESTES guidelines: acute mesenteric ischaemia. European journal of trauma and emergency surgery: official publication of the European Trauma Society. 2016. doi:10.1007/s00068-016-0634-0.

    PubMedDOI
  19. 19.
    Multidisciplinary management of acute mesenteric ischemia: Surgery and endovascular intervention. World journal of gastrointestinal surgery. 2021.
    PubMed-indexed articleReview2021

    Multidisciplinary management of acute mesenteric ischemia: Surgery and endovascular intervention. World journal of gastrointestinal surgery. 2021. doi:10.4240/wjgs.v13.i8.806.

    PubMedDOI
  20. 20.
    Advances in the diagnosis of non-occlusive mesenteric ischemia and challenges in intra-abdominal sepsis patients: a narrative review. PeerJ. 2023.
    PubMed-indexed articleReview2023

    Advances in the diagnosis of non-occlusive mesenteric ischemia and challenges in intra-abdominal sepsis patients: a narrative review. PeerJ. 2023. doi:10.7717/peerj.15307.

    PubMedDOI
  21. 21.
    Association between Postoperative Adjuvant Vasodilator Therapy and In-Hospital Mortality for Non-Occlusive Mesenteric Ischemia: A Nationwide Observational Study. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 2024.
    PubMed-indexed articleRegistry / cohort2024

    Association between Postoperative Adjuvant Vasodilator Therapy and In-Hospital Mortality for Non-Occlusive Mesenteric Ischemia: A Nationwide Observational Study. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 2024. doi:10.1272/jnms.jnms.2024_91-310.

    PubMedDOI
  22. 22.
    Endovascular Versus Open Surgical Approaches for Acute Mesenteric Ischemia: A Systematic Review of Outcomes. Cureus. 2025.
    PubMed-indexed articleMeta-analysis / systematic review2025

    Endovascular Versus Open Surgical Approaches for Acute Mesenteric Ischemia: A Systematic Review of Outcomes. Cureus. 2025. doi:10.7759/cureus.85013.

    PubMedDOI
  23. 23.
    Endovascular revascularization for treatment of acute mesenteric ischemia: a single-center experience. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology. 2026.
    PubMed-indexed articleRegistry / cohort2026

    Endovascular revascularization for treatment of acute mesenteric ischemia: a single-center experience. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology. 2026. doi:10.5114/aic.2026.160099.

    PubMedDOI
  24. 24.
    Endovascular revascularization vs open surgical revascularization as the first strategy for arterial acute mesenteric ischemia: A systematic review and meta-analysis. Journal of vascular surgery. 2024.
    PubMed-indexed articleMeta-analysis / systematic review2024

    Endovascular revascularization vs open surgical revascularization as the first strategy for arterial acute mesenteric ischemia: A systematic review and meta-analysis. Journal of vascular surgery. 2024. doi:10.1016/j.jvs.2024.07.084.

    PubMedDOI
  25. 25.
    Open Revascularization for Acute Mesenteric Ischemia is Associated with Increased Morbidity and Mortality when Compared to Endovascular Intervention. Annals of vascular surgery. 2025.
    PubMed-indexed articleRegistry / cohort2025

    Open Revascularization for Acute Mesenteric Ischemia is Associated with Increased Morbidity and Mortality when Compared to Endovascular Intervention. Annals of vascular surgery. 2025. doi:10.1016/j.avsg.2024.10.013.

    PubMedDOI
  26. 26.
    Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy. Langenbeck's archives of surgery. 2023.
    PubMed-indexed articleRegistry / cohort2023

    Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a laparotomy. Langenbeck's archives of surgery. 2023. doi:10.1007/s00423-023-03035-8.

    PubMedDOI
  27. 27.
    Acute mesenteric ischemia (Part II) - Vascular and endovascular surgical approaches. Best practice & research. Clinical gastroenterology. 2017.
    PubMed-indexed articleReview2017

    Acute mesenteric ischemia (Part II) - Vascular and endovascular surgical approaches. Best practice & research. Clinical gastroenterology. 2017. doi:10.1016/j.bpg.2016.11.003.

    PubMedDOI
  28. 28.
    Acute Mesenteric Ischemia Secondary to Superior Mesenteric Vein Thrombosis
    DOI publisher route2022
    DOI
  29. 29.
    Outcomes of different acute mesenteric ischemia therapies in the last 20 years: A meta-analysis and systematic review. Vascular. 2022.
    PubMed-indexed articleMeta-analysis / systematic review2022

    Outcomes of different acute mesenteric ischemia therapies in the last 20 years: A meta-analysis and systematic review. Vascular. 2022. doi:10.1177/17085381211024503.

    PubMedDOI
  30. 30.
    Thrombectomy Devices in the Treatment of Acute Mesenteric Ischemia: Initial Single-Center Experience. Annals of vascular surgery. 2018.
    PubMed-indexed article2018

    Thrombectomy Devices in the Treatment of Acute Mesenteric Ischemia: Initial Single-Center Experience. Annals of vascular surgery. 2018. doi:10.1016/j.avsg.2017.11.041.

    PubMedDOI
  31. 31.
    Retrograde open mesenteric stenting and outcomes for acute mesenteric ischemia. Vascular. 2025.
    PubMed-indexed articleRegistry / cohort2025

    Retrograde open mesenteric stenting and outcomes for acute mesenteric ischemia. Vascular. 2025. doi:10.1177/17085381241273265.

    PubMedDOI
  32. 32.
    Association of Perioperative Vasodilator Therapy and Mortality in Nonocclusive Mesenteric Ischemia. The Journal of surgical research. 2025.
    PubMed-indexed articleRegistry / cohort2025

    Association of Perioperative Vasodilator Therapy and Mortality in Nonocclusive Mesenteric Ischemia. The Journal of surgical research. 2025. doi:10.1016/j.jss.2025.08.017.

    PubMedDOI
  33. 33.
    Non-occlusive mesenteric ischemia: Diagnostic challenges and perspectives in the era of artificial intelligence. World journal of gastroenterology. 2021.
    PubMed-indexed articleReview2021

    Non-occlusive mesenteric ischemia: Diagnostic challenges and perspectives in the era of artificial intelligence. World journal of gastroenterology. 2021. doi:10.3748/wjg.v27.i26.4088.

    PubMedDOI
  34. 34.
    Vasodilator Therapy and Mortality in Nonocclusive Mesenteric Ischemia: A Nationwide Observational Study. Critical care medicine. 2020.
    PubMed-indexed articleRegistry / cohort2020

    Vasodilator Therapy and Mortality in Nonocclusive Mesenteric Ischemia: A Nationwide Observational Study. Critical care medicine. 2020. doi:10.1097/ccm.0000000000004255.

    PubMedDOI
  35. 35.
    The significance of possible non-occlusive mesenteric ischemia in relation to neurological outcomes in patients with refractory cardiac arrest - Secondary analysis of the Prague OHCA study. Resuscitation. 2025.
    PubMed-indexed article2025

    The significance of possible non-occlusive mesenteric ischemia in relation to neurological outcomes in patients with refractory cardiac arrest - Secondary analysis of the Prague OHCA study. Resuscitation. 2025. doi:10.1016/j.resuscitation.2025.110642.

    PubMedDOI
  36. 36.
    Preoperative prognostic predictors and treatment strategies for surgical procedure focused on the sequential organ failure assessment score in nonocclusive mesenteric ischemia: a multicenter retrospective cohort study. International journal of surgery (London, England). 2023.
    PubMed-indexed articleRegistry / cohort2023

    Preoperative prognostic predictors and treatment strategies for surgical procedure focused on the sequential organ failure assessment score in nonocclusive mesenteric ischemia: a multicenter retrospective cohort study. International journal of surgery (London, England). 2023. doi:10.1097/js9.0000000000000733.

    PubMedDOI
  37. 37.
    Indocyanine Green Tissue Angiography Can Reduce Extended Bowel Resections in Acute Mesenteric Ischemia. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2018.
    PubMed-indexed article2018

    Indocyanine Green Tissue Angiography Can Reduce Extended Bowel Resections in Acute Mesenteric Ischemia. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2018. doi:10.1007/s11605-018-3855-1.

    PubMedDOI
  38. 38.
    Predictive Factors of Intestinal Necrosis in Acute Mesenteric Ischemia: Prospective Study from an Intestinal Stroke Center. The American journal of gastroenterology. 2017.
    PubMed-indexed articleRegistry / cohort2017

    Predictive Factors of Intestinal Necrosis in Acute Mesenteric Ischemia: Prospective Study from an Intestinal Stroke Center. The American journal of gastroenterology. 2017. doi:10.1038/ajg.2017.38.

    PubMedDOI
  39. 39.
    Contrast-enhanced ultrasonographic findings of non-occlusive mesenteric ischemia: a case series. Abdominal radiology (New York). 2022.
    PubMed-indexed articleCase report2022

    Contrast-enhanced ultrasonographic findings of non-occlusive mesenteric ischemia: a case series. Abdominal radiology (New York). 2022. doi:10.1007/s00261-021-03002-1.

    PubMedDOI
  40. 40.
    Small intestinal viability assessment using dielectric relaxation spectroscopy and deep learning. Scientific reports. 2022.
    PubMed-indexed article2022

    Small intestinal viability assessment using dielectric relaxation spectroscopy and deep learning. Scientific reports. 2022. doi:10.1038/s41598-022-07140-4.

    PubMedDOI
  41. 41.
    Open abdomen in acute mesenteric ischemia. Anaesthesiology intensive therapy. 2019.
    PubMed-indexed article2019

    Open abdomen in acute mesenteric ischemia. Anaesthesiology intensive therapy. 2019. doi:10.5114/ait.2019.86280.

    PubMedDOI

Educational use only

AI assists this editorial workflow. Published updates are human-reviewed before publication.

Not intended to diagnose, monitor, predict, prognose, treat, or alleviate disease.

Verify clinically relevant information against primary sources and current guidelines.

AI DisclosurePrivacyTermsCautions